Literature DB >> 7080052

Acute toxicity of PR toxin, a mycotoxin from Penicillium roqueforti.

F C Chen, C F Chen, R D Wei.   

Abstract

The toxic effects of PR toxin were observed in mice, rats, anesthetized cats and isolated rat auricle preparations. In mice and rats the toxic effects included abdominal writhing, decrease of motor activity and respiratory rate, weakness of hindleg and ataxia. In mice, the i.p. LD50 was 5.8 mg/kg. In mice, rats and cats PR toxin given i.p. caused ascites fluid an edema in the scrotum and lungs, and i.v. injection caused edema in the lungs, giving rise to a large volume of pleural and pericardial fluid. In rats, at the LD50 dose level (11.6 mg/kg, i.p. and 8.2 mg/kg, i.v.), the water content in the lungs was increased, but in the skin it was decreased. Blood K+, hematocrit, red blood cell, white blood cell, hemoglobin, uric acid, cholesterol, blood urea nitrogen and alkaline phosphatase concentrations were all increased, while the total protein and albumin contents were decreased after i.p. injection of PR toxin. High content of protein was found in the pleural fluid and fluid due to ascites. In anesthetized cats the blood pressure and respiratory rate were progressively decreased and the heart rate was reflexly increased after i.p. injection. The i.v. injection produced a multiple response on the arterial blood pressure, but with a progressively decreasing heart rate. Arrhythmias were observed in the late shock stage in the case of i.p. or i.v. injection. In the isolated rat auricle preparations contractile force was more affected that heart rate. We conclude that PR toxin produced acute toxic effects in animals via an increase of capillary permeability and a direct damage to the lungs, heart, liver and kidney.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7080052     DOI: 10.1016/0041-0101(82)90006-x

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  10 in total

1.  Isolation and Some Properties of the Enzyme That Transforms Eremofortin C to PR Toxin.

Authors:  S C Chang; Y H Wei; M L Liu; R D Wei
Journal:  Appl Environ Microbiol       Date:  1985-06       Impact factor: 4.792

2.  Isolation, purification, and characterization of the PR oxidase from penicillium roqueforti

Authors: 
Journal:  Appl Environ Microbiol       Date:  1998-12       Impact factor: 4.792

3.  Factors affecting the production of eremofortin C and PR toxin in Penicillium roqueforti.

Authors:  S C Chang; Y H Wei; D L Wei; Y Y Chen; S C Jong
Journal:  Appl Environ Microbiol       Date:  1991-09       Impact factor: 4.792

4.  Secondary metabolites resulting from degradation of PR toxin by Penicillium roqueforti.

Authors:  S C Chang; K L Lu; S F Yeh
Journal:  Appl Environ Microbiol       Date:  1993-04       Impact factor: 4.792

5.  Chemical transformation of eremofortin C into PR toxin.

Authors:  S Y Li; S C Chang; R D Wei
Journal:  Appl Environ Microbiol       Date:  1985-09       Impact factor: 4.792

6.  Biotransformation of myrcene by Pseudomonas aeruginosa.

Authors:  Akbar Esmaeili; Elham Hashemi
Journal:  Chem Cent J       Date:  2011-05-24       Impact factor: 4.215

7.  Secondary Metabolites from Penicillium roqueforti, A Starter for the Production of Gorgonzola Cheese.

Authors:  Lisa Vallone; Alberto Giardini; Gabriella Soncini
Journal:  Ital J Food Saf       Date:  2014-09-11

Review 8.  PR Toxin - Biosynthesis, Genetic Regulation, Toxicological Potential, Prevention and Control Measures: Overview and Challenges.

Authors:  Manish K Dubey; Mohd Aamir; Manish S Kaushik; Saumya Khare; Mukesh Meena; Surendra Singh; Ram S Upadhyay
Journal:  Front Pharmacol       Date:  2018-03-29       Impact factor: 5.810

Review 9.  Germacrene A-A Central Intermediate in Sesquiterpene Biosynthesis.

Authors:  Houchao Xu; Jeroen S Dickschat
Journal:  Chemistry       Date:  2020-09-30       Impact factor: 5.236

10.  Clinical features in maxillary sinus fungus ball in patients with malignant hematological disease.

Authors:  Zhimin Xing; Lisheng Yu; Yang Yang; Xiaopei Yuan; Min Wang; Congli Geng; Yan Liu; Shichang Li; Yuanjun Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-07-03       Impact factor: 2.503

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.